NCT02480608View on ClinicalTrials.gov

Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

August 31, 2011

Study Completion Date

May 31, 2013

Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Interventions
DRUG

Imatinib

DRUG

Hydroxyurea

All Listed Sponsors
lead

University of Leipzig

OTHER

NCT02480608 - Treatment of CML Patients With Imatinib and Hydroxyurea (CML2004) | Biotech Hunter | Biotech Hunter